Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
BriovaRx was a U.S. specialty pharmacy and infusion services business focused on dispensing and supporting specialty medications for patients with complex, chronic, or rare conditions. The business provided specialty pharmacy fulfillment, clinical support, patient education, benefits and reimbursement assistance, and home infusion services. BriovaRx operated as the specialty pharmacy brand associated with OptumRx and was ultimately folded into the Optum Specialty Pharmacy and Optum Infusion Pharmacy brands beginning in late 2019 and through 2020. It was healthcare-services oriented rather than a drug developer, so it did not have a traditional therapeutic pipeline.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on BriovaRx.